Akzo Nobel Posts Higher Q2 Profit, Reaffirms Full-Year Outlook Amid Axalta Merger Progress

Akzo Nobel N.V. (AKZA.AS) reported a rise in second-quarter net income attributable to shareholders, reaching €139 million compared to €124 million in the prior-year period. Basic earnings per share climbed to €0.81 from €0.72.

Adjusted EBITDA increased to €398 million from €393 million, with organic adjusted EBITDA growth of €18 million driven by pricing improvements. Adjusted earnings per share from continuing operations stood at €1.07, compared to €1.13 a year earlier. Quarterly revenue dipped slightly to €2.59 billion from €2.63 billion, though organic sales grew 2%.

Looking ahead, the company targets €100 million of adjusted EBITDA improvement in constant currencies. For 2026, adjusted EBITDA is expected to reach at least €1.47 billion, based on year-end 2025 exchange rates and adjusted for the India divestment. Over the mid-term, AkzoNobel aims to achieve an adjusted EBITDA margin above 16% and a return on investment between 16% and 19%.

CEO Greg Poux-Guillaume stated: “Our merger with Axalta is progressing as planned, with the shareholder vote on August 5 and an expected closing at the end of 2026 or early 2027. And we remain on track to achieve our full-year targets.”

At the last close, Akzo Nobel shares were trading at €57.16, down 0.45%.

Source link